About Archimica Products Technologies & Plant Quality model News Contacts CPhI Worldwide 2021 in Milano | Archimica We are happy to announce that Archimica S.p.A will be exhibiting at CPhI Worldwide 2021 in Milano. Our Team will attend the event from the 9th - 11th of November at Fiera Read more Archimica July Press Release Expansion of Multi-Purpose Manufacturing Capacity July 22, 2021 Archimica announces completion of its 1,2 Mio. Euro Investment Expansion of its Multi-Purpose Manufacturing Capacity on CPHI North America Archimica has started the operation of its expanded Read more CPHI Philadelphia Virtual Edition 2021 Archimica is pleased to announce that will attend CPHI Philadelphia Virtual Edition 2021. Join us for online meeting from 2 August to 6 August! Schedule a meeting https://www.archimica.com/ Read more We Are Hiring Send Us the resume CV: contact@archimica.com Read more Archimica Press Release Laboratory Expansion May 2021 25 May 2021 Archimica invests 1,3 Mio. Euro in Expansion of Process Development Capacity Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. A Read more L-α-Glycerophosphoryl-ethanolamine (GPE) L-α-Glycerophosphoryl-ethanolamine (GPE) is a precursor of neurotransmitters located in the lipid membranes of cells. Scientific studies show that modifications of these membranes are contributing factors in disease or age-related memory Read more We Are Hiring Send Us the resume CV: contact@archimica.com Read more OXCARBAZEPINE API Oxcarbazepine is an important drug in treatment of epilepsy and related disorders. It is successfully applied to patients globally in a wide variety of presentations. Recent more stringent quality requirements Read more Search for: Categories News Events News Tag #activeingredients #apidevelopment #apidrug #archimica #biotechnology #businessdevelopment #capability #cdmo #chemical #chimical #clinicalresearch #cphi #CPHI2021 #CPhIworldwide #development #druganalysis #equiment #event #expansion #FDA #genericdrugs #genericpharma #gmp #hiring #industry #innovation #investiments #laboratory #lifesciences #manager #manufacturing #multipurpose #newjob #opportunity #pharma #Pharmaceuticalindustry #pharmaceuticals #pharmadrugs #reactor #researchanddevelopment #supplyAPI #supplydrug API cphimilano madeinitaly Latest News CPhI Worldwide 2021 in Milano | Archimica Archimica July Press Release Expansion of Multi-Purpose Manufacturing Capacity CPHI Philadelphia Virtual Edition 2021 We Are Hiring Archimica Press Release Laboratory Expansion May 2021 See further News See further News Select Month September 2021 July 2021 May 2021 February 2021 ARCHIMICA S.p.A. LEGAL ADDRESS Viale Milano 86, 26900 Lodi (LO) - ITALY SITE ADDRESS Viale Milano 86, 26900 Lodi (LO) - ITALY CONTACTS Phone: +39 0371 49021 Fax: +39 0371 610019 email: contact@archimica.com FEI Number: 3002874947 DUNS Number: 429351620 API Reg. Form: AMA – 26/2015 GMP Certificate: NBF/10/2015V All the documents are available for download from EurdaGMP web site www.eudragmdp.ema.europa.eu Terms and Conditions Sales Terms and Conditions Purchase © 2019 Copyright Archimica S.p.A | P.I. & C.F. 07254610152 | Cap. Soc. € 10.207.131,30 iv - R.E.A. 1851470 Isc. Reg. Imp. di Lodi | All media belong to their respective owners. | Privacy Policy We use cookies to make sure you can have the best experience on our site. By continuing to browse, you accept the use of cookies, otherwise you can leave the site.OkTerms & Conditions Welcome! Discover our last Company Profile. DOWNLOAD HERE